Endogenous galectin-3 determines the routing of CD95 apoptotic signaling pathways

Tomoharu Fukumori1, Yukinori Takenaka, Natsuo Oka

  • 1Tumor Progression and Metastasis Program, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

Cancer Research
|May 20, 2004
PubMed

Insights

Galectin-3 determines cell fate in CD95 (APO-1/Fas) signaling. This antiapoptotic molecule directs cells toward type I apoptosis, preventing mitochondrial involvement and promoting survival.

Area of Science:

  • Cell biology
  • Molecular biology
  • Immunology

Background:

  • CD95 (APO-1/Fas) receptor initiates apoptosis via two distinct pathways: type I (caspase-8 dependent) and type II (mitochondria dependent).
  • The specific pathway activated by apoptotic insults remains largely undetermined.
  • Galectin-3, an antiapoptotic protein, possesses a conserved motif similar to Bcl-2 family proteins.

Purpose of the Study:

  • To investigate the role of galectin-3 in regulating CD95 apoptotic signaling pathways.
  • To identify galectin-3 as a potential determinant of type I versus type II apoptosis.
  • To explore the interaction between galectin-3 and the CD95 receptor.

Main Methods:

  • Cellular expression analysis of galectin-3 in type I and type II apoptotic phenotypes.
  • Galectin-3 cDNA transfection into galectin-3 null cells to assess phenotypic changes.
  • In vivo co-immunoprecipitation assays to detect galectin-3 and CD95 complex formation.

Main Results:

  • Galectin-3 expression was exclusively observed in type I apoptotic cells.
  • Transfection of galectin-3 into type II cells induced a type I apoptotic phenotype.
  • Galectin-3 was identified as a novel binding partner of CD95 in vivo.

Conclusions:

  • Galectin-3 dictates the selection of the CD95 apoptotic signaling pathway.
  • Galectin-3 promotes a type I apoptotic response, favoring caspase-8 activation over mitochondrial pathways.
  • The interaction of galectin-3 with CD95 is a key mechanism controlling cell death decisions.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...